Time-trend impact on treatment estimation in two-arm clinical trials with a binary outcome and Bayesian response adaptive randomization

被引:9
作者
Jiang, Yunyun [1 ]
Zhao, Wenle [2 ]
Durkalski-Mauldin, Valerie [2 ]
机构
[1] George Washington Univ, Dept Epidemiol & Biostat, 6110 Execut Blvd, Rockville, MD 20852 USA
[2] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA
关键词
Bayesian response adaptive randomization; time-trend; bias; adaptive allocation; clinical trial; OFFER ADVANTAGES; DESIGN; ALGORITHM;
D O I
10.1080/10543406.2019.1607368
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Clinical trial design and analysis often assume study population homogeneity, although patient baseline profile and standard of care may evolve over time, especially in trials with long recruitment periods. The time-trend phenomenon can affect the treatment estimation and the operating characteristics of trials with Bayesian response adaptive randomization (BRAR). The mechanism of time-trend impact on BRAR is increasingly being studied but some aspects remain unclear. The goal of this research is to quantify the bias in treatment effect estimation due to the use of BRAR in the presence of time-trend. In addition, simulations are conducted to compare the performance of three commonly used BRAR algorithms under different time-trend patterns with and without early stopping rules. The results demonstrate that using these BRAR methods in a two-arm trial with time-trend may cause type I error inflation and treatment effect estimation bias. The magnitude and direction of the bias are affected by the parameters of the BRAR algorithm and the time-trend pattern.
引用
收藏
页码:69 / 88
页数:20
相关论文
共 28 条
[1]   THE HIDDEN EFFECT OF TIME [J].
ALTMAN, DG ;
ROYSTON, JP .
STATISTICS IN MEDICINE, 1988, 7 (06) :629-637
[2]   Early stopping of randomized clinical trials for overt efficacy is problematic [J].
Bassler, Dirk ;
Montori, Victor M. ;
Briel, Matthias ;
Glasziou, Paul ;
Guyatt, Gordon .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2008, 61 (03) :241-246
[3]   A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic response [J].
Berry, Scott M. ;
Petzold, Elizabeth A. ;
Dull, Peter ;
Thielman, Nathan M. ;
Cunningham, Coleen K. ;
Corey, G. Ralph ;
McClain, Micah T. ;
Hoover, David L. ;
Russell, James ;
Griffiss, J. McLeod ;
Woods, Christopher W. .
CLINICAL TRIALS, 2016, 13 (01) :22-30
[4]   Continuous Bayesian adaptive randomization based on event times with covariates [J].
Chappell, Rick ;
Karrison, Theodore .
STATISTICS IN MEDICINE, 2007, 26 (15) :3050-3052
[5]   Optimal adaptive randomized designs for clinical trials [J].
Cheng, Yi ;
Berry, Donald A. .
BIOMETRIKA, 2007, 94 (03) :673-689
[6]   Do Bayesian adaptive trials offer advantages for comparative effectiveness research? Protocol for the RE-ADAPT study [J].
Connor, Jason T. ;
Luce, Bryan R. ;
Broglio, Kristine R. ;
Ishak, K. Jack ;
Mullins, C. Daniel ;
Vanness, David J. ;
Fleurence, Rachael ;
Saunders, Elijah ;
Davis, Barry R. .
CLINICAL TRIALS, 2013, 10 (05) :807-827
[7]   Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus [J].
Connor, Jason T. ;
Elm, Jordan J. ;
Broglio, Kristine R. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2013, 66 (08) :S130-S137
[8]  
Cook J. D., 2012, UT MD ANDERSON CANC
[9]   Stopping clinical trials early for benefit: impact on estimation [J].
Freidlin, Boris ;
Korn, Edward L. .
CLINICAL TRIALS, 2009, 6 (02) :119-125
[10]   A WEAKLY INFORMATIVE DEFAULT PRIOR DISTRIBUTION FOR LOGISTIC AND OTHER REGRESSION MODELS [J].
Gelman, Andrew ;
Jakulin, Aleks ;
Pittau, Maria Grazia ;
Su, Yu-Sung .
ANNALS OF APPLIED STATISTICS, 2008, 2 (04) :1360-1383